We have investigated the transcriptional regulation of the human cytomegalovirus y gene encoding the ICP36 family (p52, the major late DNA-binding protein). The ICP36 transcription unit initiates at three distinct sites which are separated by approximately 50 nucleotides and are differentially regulated during infection. At early times (8 h postinfection), only two of these start sites, the most proximal and distal site, were active whereas at late times (36 h postinfection), the middle start site was activated. Expression from this late start site was dependent upon DNA replication. Consensus TATA elements were located upstream of all three start sites, although the element upstream of the late start site was unusual in both sequence and position when compared with conventional TATA elements. Deletion analysis was used in conjunction with transient assays to define independent promoters in this region. The two early start sites and associated TATA elements functioned as separable independently regulated promoters. The region containing the late start site and TATA element but excluding either of the flanking TATA elements was inactive in transient assays. Our work establishes that the ICP36 gene is under complex early and late transcriptional regulation and that the sequences regulating transcriptional activation are temporally and spatially distinct.
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Cytomegalovirus (CMV) has a large 230-kilobase-pair (kbp) DNA genome that carries nearly 200 open reading frames (ORFs) (57; M. Chee, A. T. Bankier, and B. G. Barrell, personal communication). In CMV, as in other herpesviruses, regulated expression of the ot (immediateearly), P (delayed-early), and y (late) genes occurs as an ordered cascade controlled at the transcriptional level by viral transactivators (13, 14, 22, 32, 40, 43, 46, 50, 52, 58, 64, 65 ; for recent reviews, see references 37 and 63) . The most prominent locus of CMV a gene expression is transcriptionally controlled by a promoter with an adjacent strong enhancer (1, 6, 12, 53-55, 59, 61, 66) that is responsive to virion transactivation (50, 58) . Transcriptional events also play a role in the regulation of and -y gene expression (11, 34, 35, 50, 64, 65) , and some y gene transcription is strictly dependent on DNA replication (31) . It appears that posttranscriptional events are important in the overall regulation of early and late gene expression (10, 15-17, 20, 64) . The cis-acting regulatory elements controlling ,B and -y transcription have not been fully analyzed, although there is accumulating evidence that a family of related ot gene protein products plays an important role as transactivators of viral gene expression (22, 43, 51, 52, 60) .
Studies of regulation of herpes simplex virus (HSV) lategene expression have concentrated on those few y genes (so-called _Y2) whose expression is strictly dependent on viral DNA replication (9, 23, 26, 27) , work that has centered on the detailed analysis of three viral genes: the US11 gene (28) , the glycoprotein C gene (3, 4, 24, 25) and a gene encoding a 70-kilodalton regulatory protein (32, 46) . In contrast to their behavior within the viral genome, Y2 promoter-regulators act as promoter-regulators when isolated and assayed outside of the viral genome (3, 4, 46) . Studies directed toward dissecting authentic late-specific regulation have therefore depended on the construction of viral recombinants (24, 25, distinct elements are important in the regulation of at least one HSV late gene.
In CMV, the ICP36 transcript is expressed by 4 h postinfection (p.i.), long before the protein products are maximally synthesized (15, 19) . Therefore, transcriptional activation of this gene appears to precede its full expression. ICP36 transcription initiates at three distinct sites spaced approximately 50 bp apart (15 
MATERIALS AND METHODS
Virus and cells. Human CMV (Towne) was grown, and the titers of the virus on human foreskin fibroblast (HF) cells were determined as previously described (49) . COS-7 cells were grown and transfected with 10 to 30 ,ug of plasmid using DEAE-dextran (Pharmacia, Inc., Piscataway, N.J.) as previously described (21, 50 Fig. 2. A series of ICP36 promoter-regulator fragments derived from pON237 (15) (Fig. 1) (Fig. 1) , followed by the addition of a Sall linker to mark the deletion endpoint (see Fig. 6 ). pON296 was likewise generated by BAL 31 digestion from the unique KpnI site in pON262 with the subsequent cloning of a XhoI-XbaI fragment into SalI-XbaI-digested pON1. Additional plasmids with BAL 31-generated deletions (pON269 and pON270) were generated from the unique PvuII site in pON254, followed by the addition of an XbaI linker to mark the deletion endpoint and cloning of XhoI-XbaI fragments into SalI-XbaI-digested pON1. Other centrifuging at 2,500 x g for 10 min to remove nuclei. The nuclear pellet was discarded, and an equal volume of a solution of 50 mM Tris hydrochloride (pH 7.5), 400 mM NaCl, 20 mM EDTA, and 1.0% sodium dodecyl sulfate was added to the supernatant. Proteinase K (predigested for 2 h at 37°C) was added to a final concentration of 0.1 mg/ml, and after incubation at 37°C for 20 min, CsCl was added to 1.4 M and sodium acetate was added to 10 mM. The RNA was then pelleted through a 5.7 M CsCl cushion as previously described for whole-cell RNA (15) . Primer extension (44) was performed with an end-labeled 79-nt primer prepared from
XbaI-DpnI-digested pON262. The hybridization conditions were as described for S1 nuclease analysis (5, 15), and the primer was strand separated prior to use (30) . Immunoblot analysis. Transfected or mock-transfected COS-7 cells were solubilized directly for sodium dodecyl sulfate-polyacrylamide gel electrophoresis and separated on 9.25% gels as previously described (15, 38) . Western blot (immunoblot) analysis was also done as previously described (15) . Monoclonal antibodies to ICP36 (CH16-1 and CH13-2)
were kindly provided as ascites fluids by L. Pereira (42) .
RESULTS
Position of the ICP36-coding sequences. The structure of the ICP36 transcription unit ( Fig. 1 ) was previously determined by S1 nuclease mapping and RNA blot analysis (15, 38) . In order to position the ICP36 protein-coding region within the 4.5-kb transcript, processive 3' deletions of the transcription unit were constructed and tested for expression in COS-7 cells without concurrent CMV infection (Fig. 2) . At 72 h posttransfection, cell lysates were subjected to immunoblot analysis with ICP36-specific monoclonal antibodies CH16-1 and CH13-2 (15, 38) . Constructs containing the first 1.5 kbp of the transcription unit (pON2052), as well as deletion mutants (pON2053 and pON2054) produced an immunoreactive protein that comigrated with the largest and most abundant species of the ICP36 family (ICP36b) (Fig. 2 ). pON2055 produced one major high-molecular-weight immunoreactive protein with an apparent molecular weight of 66,000 that, based on the nucleotide sequence in this region, represents an in-frame fusion between the ICP36-coding region and a downstream ORF encoding an x protein (29, 66) . pON2055 also produced reactive bands that comigrated with smaller ICP36 species (ICP36e). As expected from the removal of the monoclonal antibody epitopes which map downstream of the BglII site (38), pON2056 did not express protein recognized by ICP36-specific antibodies. On the basis of the nucleotide sequence in this region, the deletion of 2.5 kbp in pON2056 would result in a 115-amino-acid polypeptide containing the ICP36 amino terminus and a short stretch of amino acids derived from a region downstream of the fusion point ( Fig. 2; 15, 38 ; C. M. Brown, A. T. Bankier, and B. G. Barrell, personal communication). ICP36-specific RNA was expressed from pON2056 to similar levels as those of the other constructs, indicating that transcription was not affected by the deletion (data not shown). This analysis mapped the ICP36-coding sequences to the 5' 1.5 kb of the 4.5-kb ICP36 RNA (15 (15) , three major extended products (labeled start sites 1, 2, and 3) were observed in infected-cell RNA (Fig. 3A) . Start site 2 consisted of one major and one minor species separated by 4 nt, which could represent either heterogeneous starts or a premature stop by reverse transcriptase. Nucleotide sequence analysis showed A-T-rich elements upstream of each start site (Fig.  3B) . The A-T-rich elements upstream of start sites 1 and 3 clearly fit the consensus TATA box sequence (39) Differential use of ICP36 transcription start sites. We used S1 analysis to investigate the differential use of ICP36 transcription start sites. S1 analyses were performed on total poly(A)+ RNA and cytoplasmic RNA was isolated from CMV-infected cells at 8, 24, and 48 h p.i. (Fig. 4A) pON268 as described in Materials and Methods. This construct was compared with two previously described constructs, pON249, an (x promoter-regulator, and pON241, a 3 promoter-regulator (16, 50) , by transient transfection-infection assay in HF cells. This promoter-regulatory region was transactivated by CMV and expressed I3Gal in a temporal manner (Fig. 5) , indicating it functioned as a 3 promoter in transient transfection-infection assays. The time of activation in transient assays corresponded to the time of activation of start sites 1 and 3 during natural CMV infection (Fig.   4 ). As would be expected, pON268 activation was not affected by PFA in this assay (data not shown). This DNA fragment contained the three start sites and more than 400 bp upstream of start site 1, as well as the ICP36 ATG codon (Fig. 3B) . As a result of stop codons within the polylinker sequences downstream of the fusion to IacZ sequences in pON268, translational initiation at this ATG codon would be terminated upstream of the lacZ translation initiation codon (21, 50) . Any translation initiation at this site did not substantially reduce expression of the IchZ insert in pON268 relative to pON269 in which the sequences including the ATG were deleted (Table 1) . Thus, we conclude that pON268 and pON269 carry the ICP36 promoter-regulator as indicated by the transient assay.
Deletion analysis was used to dissect the promoter-regulator region and identify cis-acting signals responsible for viral transactivation. The 600-bp ICP36 promoter-regulator fragment carried by pON268 was dissected into fragments containing none, one, two, or all three TATA elements with various amounts of flanking sequence ( Fig. 1 (Table   1) . Thus, this 266-bp promoter-regulator was sufficient for VOL. 63, 1989 on October 28, 2017 by guest http://jvi.asm.org/ Downloaded from A CYTO P U 8 48 Fig. 1 (Fig. 3B) 
